Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Clinical trial NCT01568489 · COMPLETED

Trial details

NCT number: NCT01568489
Sponsor: HanAll BioPharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Atopic Dermatitis

Start date: 2012-04-09
Primary completion: 2013-06-11
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.